Additionally, there can also be a suppression of MDR1/P- glycoprotein activity during AKI, and this may have an impact on the clearance of drugs such as digoxin, methotrexate, and vincristine [8,10]. The gene discussed is ABCB1; the disease is acute kidney injury.